HomeTherapeutic areasOncology › Chronic Lymphocytic Leukemia

Chronic Lymphocytic Leukemia (2 companies)

Companies with an active program in Chronic Lymphocytic Leukemia.

Ticker Company Therapeutic areas Programs Lead stage Programs
AUTL Autolus Therapeutics HematologyImmunology+3 Rare 1 Approved 12
NRIX Nurix Therapeutics ImmunologyNeurology+1 2 Phase 2 15